HPV awareness and HIV prevention

By tsmith on August 15, 2006.

I've blogged previously about the massive effect vaccines against the human papilloma virus (HPV) could have. HPV is a common sexually-transmitted virus. Though most strains are harmless, a few have the potential to cause cervical cancer. Therefore, the HPV vaccine will be the first one ever specifically intended to prevent a type of cancer.

This vaccine has recently been approved by the FDA, and is set to roll out shortly. This is already expected to be a rather contentious issue as the vaccine is rolled out in the U.S. and elsewhere, as one target group for vaccination is adolescents who have not yet begun sexual activity. Some religious groups have already objected on the grounds that it will increase sexual promiscuity.

A Monday session The Potential Role of HPV Vaccines in Improving HIV Prevention Among Young Girls and Women (video at link) suggested that the coming controversy (and hopeful resolution) over adoption of the HPV vaccine could be used as both a model for an eventual HIV vaccination campaign, as well as begin to open the dialogue among parents, teens, caregivers, and public health officials regarding issues in adolescent sexual activity.

(Continued at AIDS at 25)

More like this

Merck drops HPV lobbying (updated)

In June, we talked about a new human papiloma virus (HPV) vaccine that was being opposed by a Christian group in Colorado on the grounds that it might promote premarital sex. HPV is a virus that commonly infects the female reproductive tract. It has many strains, and some of those strains confer…

HPV Vaccine May Be Required in Michigan

GARDASIL®, the vaccine intended to prevent infection with href="http://en.wikipedia.org/wiki/Human_papilloma_virus" rel="tag">human papillomavirus (HPV), was controversial even before it was href="http://www.cbsnews.com/stories/2006/05/18/health/main1628221.shtml">approved by the FDA…

Cervical cancer vaccine and politics as ususal

As mentioned in the comments to this post, there is a brewing controversy over upcoming guidelines outlining who should receive the "cervical cancer vaccine," a vaccine against the human papilloma virus (HPV). Briefly, the HPV vaccine is a highly effective (100% in a 2-year clinical trial) vaccine…

The potential of papilloma virus vaccines

I discussed the so-called "cervical cancer vaccine," a multivalent vaccine protective against several strains of the human papilloma virus previously here. In the new issue of the New England Journal of Medicine, there's a perspective on the vaccine, and issues surrounding it: Genital HPV…

Advertisment

Donate

ScienceBlogs is where scientists communicate directly with the public. We are part of Science 2.0, a science education nonprofit operating under Section 501(c)(3) of the Internal Revenue Code. Please make a tax-deductible donation if you value independent science communication, collaboration, participation, and open access.

You can also shop using Amazon Smile and though you pay nothing more we get a tiny something.

Science 2.0

Science Codex

More by this author

Movin'...

October 18, 2017

As several others have already noted, after almost 12 years, Scienceblogs is shutting down at month's end. Though I've done most of my writing elsewhere over the last few years, I'd certainly like to keep the archives of this blog up somewhere, and maintain it as a place to post random musings that…

The high cost of academic reimbursement

September 29, 2017

Spring, 2004. I was in the second year of my post-doc, with kids ages 4 and 2. Because I was no longer a student, the full brunt of my student loan payments had hit me, which were collectively almost double the cost of my mortgage. To put it generously, money was tight. Truthfully, we were broke as…

Vaccine advocacy 101

July 26, 2017

I recently finished a 2-year stint as an American Society for Microbiology Distinguished Lecturer. It's an excellent program--ASM pays all travel expenses for lecturers, who speak at ASM Branch meetings throughout the country. I was able to attend Branch meetings from California and Washington in…

Is there such a thing as an "evolution-proof" drug? (part the third)

May 31, 2017

A claim that scientists need to quit making: I've written about these types of claims before. The first one--a claim that antimicrobial peptides were essentially "resistance proof," was proven to be embarrassingly wrong in a laboratory test. Resistance not only evolved, but it evolved…

HIV's "Patient Zero" was exonerated long ago

October 27, 2016

The news over the past 24 hours has exclaimed over and over: HIV's Patient Zero Exonerated How scientists proved the wrong man was blamed for bringing HIV to the U.S. Researchers Clear "Patient Zero" from AIDS Origin Story H.I.V. Arrived in the U.S. Long Before ‘Patient Zero’ Gaetan Dugas: "patient…